Search research articles
Contact Us
Filters
Showing results (111-120 of 192) with videos related to
Page
of 20
Sort By:
Journal of Clinical Pharmacology
|
January 7, 2026
Bioequivalence Assessment for Intranasal Rapid-Acting Drug Products
Zhijun Kevin Wang, Shein Chung Chow, Moses S S Chow
Statistics in Medicine
|
August 31, 2012
Scientific considerations for assessing biosimilar products
Shein-Chung Chow, Jun Wang, Laszlo Endrenyi, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2011
Imputation method adjusted for covariates for nonrespondents in instruments with applications
Juan Li, Eric M Chi, Chunyao Feng, et al.
Journal of Biopharmaceutical Statistics
|
August 8, 2014
Scientific factors and current issues in biosimilar studies
Shein-Chung Chow, Laszlo Endrenyi, Peter A Lachenbruch, et al.
Journal of Biopharmaceutical Statistics
|
June 2, 2012
Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution
Qingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.
Journal of Biopharmaceutical Statistics
|
February 26, 2010
On assessing bioequivalence using genomic data with model misspecification
Qingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
A comparison of moment-based and probability-based criteria for assessment of follow-on biologics
Shein-Chung Chow, Tsung-Cheng Hsieh, Eric Chi, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
Statistical methods for assessment of biosimilarity using biomarker data
Shein-Chung Chow, Qingshu Lu, Siu-Keung Tse, et al.
Therapeutic Innovation & Regulatory Science
|
March 3, 2025
A Proposed Confidence Ellipse Approach for Benefit-Risk Assessment in Clinical Trials
Yinuo Zhang, Xiaofang Zhang, Peijin Wang, et al.
Statistics in Medicine
|
August 31, 2012
Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics
Nan Zhang, Jun Yang, Shein-Chung Chow, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 192) with videos related to
Sort By:
Page
of 20
Journal of Clinical Pharmacology
|
January 7, 2026
Bioequivalence Assessment for Intranasal Rapid-Acting Drug Products
Zhijun Kevin Wang, Shein Chung Chow, Moses S S Chow
Statistics in Medicine
|
August 31, 2012
Scientific considerations for assessing biosimilar products
Shein-Chung Chow, Jun Wang, Laszlo Endrenyi, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2011
Imputation method adjusted for covariates for nonrespondents in instruments with applications
Juan Li, Eric M Chi, Chunyao Feng, et al.
Journal of Biopharmaceutical Statistics
|
August 8, 2014
Scientific factors and current issues in biosimilar studies
Shein-Chung Chow, Laszlo Endrenyi, Peter A Lachenbruch, et al.
Journal of Biopharmaceutical Statistics
|
June 2, 2012
Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution
Qingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.
Journal of Biopharmaceutical Statistics
|
February 26, 2010
On assessing bioequivalence using genomic data with model misspecification
Qingshu Lu, Siu-Keung Tse, Shein-Chung Chow, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
A comparison of moment-based and probability-based criteria for assessment of follow-on biologics
Shein-Chung Chow, Tsung-Cheng Hsieh, Eric Chi, et al.
Journal of Biopharmaceutical Statistics
|
January 16, 2010
Statistical methods for assessment of biosimilarity using biomarker data
Shein-Chung Chow, Qingshu Lu, Siu-Keung Tse, et al.
Therapeutic Innovation & Regulatory Science
|
March 3, 2025
A Proposed Confidence Ellipse Approach for Benefit-Risk Assessment in Clinical Trials
Yinuo Zhang, Xiaofang Zhang, Peijin Wang, et al.
Statistics in Medicine
|
August 31, 2012
Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics
Nan Zhang, Jun Yang, Shein-Chung Chow, et al.
Page
of 20